Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-03-22 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
诺禾致源关于第三届董事会第六次会议相关事项的独立意见
Capital/Financing Update Classification · 95% confidence The document is an independent director's opinion on extending the validity period of a shareholders' resolution related to a specific private placement of shares. It discusses legal compliance and procedural matters regarding the extension of authorization for the board to handle the issuance. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a regulatory announcement related to capital issuance but does not announce the issuance itself or provide financial results. Given the content and length (1104 characters), it is not a full report but an announcement related to capital/financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-03-22 Chinese
诺禾致源关于延长公司2022年度向特定对象发行A股股票股东大会决议有效期及相关授权有效期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Beijing Nuohe Zhiyuan Technology Co., Ltd. regarding the extension of the validity period of a shareholders' meeting resolution and related authorization concerning a specific issuance of A shares to particular investors. It discusses board and shareholder meeting decisions about extending the validity of a prior resolution and authorization for a share issuance. The document is short (1082 characters) and primarily serves as a formal announcement of these corporate governance actions related to capital issuance. It does not contain financial statements, detailed financial data, or comprehensive report content. Therefore, it is best classified as a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2023-03-22 Chinese
北京诺禾致源科技股份有限公司2022年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2022 年度业绩快报公告" which translates to "2022 Annual Performance Express Report Announcement." It contains preliminary financial data for the year 2022, including revenue, profit, and asset figures, but explicitly states that the data is unaudited and that the final audited data will be in the 2022 Annual Report. The document is relatively short (1664 characters) and serves as a quick earnings update rather than a full comprehensive report. It does not contain detailed financial statements or extensive analysis typical of an Annual Report (10-K) or Interim Report (IR). It is also not a simple announcement of report publication but a brief financial performance announcement. This type of document aligns with an Earnings Release (ER), which provides initial key financial results highlights for a fiscal year or quarter. FY 2022
2023-02-27 Chinese
诺禾致源关于向特定对象发行股票申请获得中国证券监督管理委员会同意注册批复的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Beijing Novogene Technology Co., Ltd. regarding the approval from the China Securities Regulatory Commission (CSRC) for the company's application to issue shares to specific investors. It mentions the registration approval, the validity period, and the company's commitment to comply with regulations and disclose information timely. The content focuses on a capital raising event through a specific share issuance and the regulatory approval thereof. The document length is short (822 characters), and it is not a full financial report but an announcement of a regulatory approval related to capital issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-11-15 Chinese
诺禾致源关于召开2022年第三季度业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about a scheduled investor meeting to discuss the company's third quarter 2022 financial results. It specifies the date, time, location, and format of the meeting, and invites investors to participate and ask questions. The document does not contain actual financial statements or detailed financial analysis but serves to inform about the upcoming earnings explanation session. This fits the description of a Call Transcript (CT) precursor or an Earnings Release (ER) related event. However, since it is an announcement of the earnings explanation meeting rather than the earnings release itself or the transcript, it is best classified as an Investor Presentation (IP) announcement or related event. Given the detailed description of the meeting and its purpose to discuss financial results, the closest fitting category is Investor Presentation (IP).
2022-11-02 Chinese
诺禾致源2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2022 年第三季度报告" which translates to "2022 Third Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2022. The report explicitly states it is unaudited and covers the period ending September 30, 2022. The content includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, which matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2022
2022-10-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.